TECNOTREE
7.8.2024 11:59:35 CEST | Business Wire | Press release
Tecnotree, a global leader in digital platforms and services for AI, 5G, and cloud-native technologies, has been mentioned in three different 2024 Gartner Hype Cycle reports, recently published. Tecnotree has been cited under the categories of Hype Cycle for Enterprise Communication Services, Private Mobile Network Services, and Operations and Automation in Communications Industry, 2024. We believe that these recognitions highlight Tecnotree’s excellence in Partner Ecosystem Management Platforms for CSPs and CSP Digital Marketplaces for Tecnotree Moments Partner Ecosystem Platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240807343127/en/
Tecnotree Recognized in 3 Different 2024 Gartner® Hype Cycle™ Reports, for Partner Ecosystem Management Platforms for CSPs, CSP Digital Marketplaces, and AI for CSP Customer Interactions Categories (Graphic: Business Wire)
As per Gartner, “Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are potentially relevant to solving real business problems and exploiting new opportunities. Gartner Hype Cycle methodology gives you a view of how a technology or application will evolve over time, providing a sound source of insight to manage its deployment within the context of your specific business goals.” Digital marketplaces are an increasingly important part of the CSPs’ go-to-market strategy for digital services and small-and-midsize-business (SMB) and consumer segments. CSPs can enrich their offerings with partner solutions, drive data insights on buyer behavior, and implement automation for faster cycles and improved digital engagement. CSPs can use marketplaces to differentiate from competitors through expanding portfolio with partner offerings, ease-of-use, automation, composable bundles, verticalization and locally tailored offerings.
Tecnotree Moments powered by TM Forum certified Open APIs and Open Digital Architecture (ODA) compliant, provides superior digital experience management operations with advertising and partner led campaign management solutions for aim driven product recommendations, customer journey orchestration, partner management, content and channel personalisation, and dynamic loyalty programs. The Tecnotree Moments multi experience platform using Azure and AWS cloud infrastructure with multitenancy capabilities. The low/no code platform provides intelligence enabled customer experience, based on AI & ML and automation utilizing cloud technologies.
Tecnotree Moments, marketplace accelerates time to market, extends outreach to target segments, expands partner ecosystems, and speeds up the sales cycle. For CSPs, marketplaces target increased self-service and digital engagement, revenue growth, tailored solutions that can be composed based on the needs of each buyer, and actionable data insights on purchase behavior that can inform product developers and enrich the support of ecosystem partners.
Padma Ravichander, CEO, Tecnotree Corporation said, “We are thrilled to be acknowledged in three of the Gartner Hype Cycles. We believe that this recognition underscores our forward-looking vision unwavering commitment to delivering unparalleled value by redefining digital experiences and enhancing revenue monetization capabilities for our customers. Leveraging AI, 5G, and cloud-native technologies, we drive innovation that empowers CSPs with personalized, highly secure solutions. Our inclusion in these reports validates our dedication to pushing the boundaries and continuously expanding our use of AI applications to improve productivity, efficiency, and customer experience.”
Gartner, Hype Cycle for Customer Experience and Monetization in the Communications Industry, 2024, By Susan Welsh de Grimaldo, Pulkit Pandey, 25 July 2024.
Gartner, Hype Cycle for Enterprise Communication Services, 2024, By Khurram Shahzad, 16 July 2024.
Gartner, Hype Cycle for Operations and Automation in the Communications Industry, 2024, By Mounish Rai, Amresh Nandan, 23 July 2024.
Gartner Research Methodologies, Gartner Hype Cycle, August 5, 2024, https://www.gartner.com/en/research/methodologies/gartner-hype-cycle
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807343127/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom